BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

239 related articles for article (PubMed ID: 27026878)

  • 1. Potential problems and recommendations regarding substitution of generic antiepileptic drugs: a systematic review of literature.
    Atif M; Azeem M; Sarwar MR
    Springerplus; 2016; 5():182. PubMed ID: 27026878
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Generic antiepileptic drugs-Safe or harmful in patients with epilepsy?
    Holtkamp M; Theodore WH
    Epilepsia; 2018 Jul; 59(7):1273-1281. PubMed ID: 29894004
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Generic substitution of antiepileptic drugs: a systematic review of prospective and retrospective studies.
    Yamada M; Welty TE
    Ann Pharmacother; 2011 Nov; 45(11):1406-15. PubMed ID: 22028417
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Recommendations of the Italian League against Epilepsy working group on generic products of antiepileptic drugs.
    Perucca E; Albani F; Capovilla G; Bernardina BD; Michelucci R; Zaccara G
    Epilepsia; 2006; 47 Suppl 5():16-20. PubMed ID: 17239100
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Generic substitution for brand name antiepileptic drugs: a survey.
    Guberman A; Corman C
    Can J Neurol Sci; 2000 Feb; 27(1):37-43. PubMed ID: 10676586
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Generic substitution of anti-epileptic drugs. A needed battle?
    Al-Baradie RS
    Neurosciences (Riyadh); 2008 Jul; 13(3):211-6. PubMed ID: 21063327
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Generic products of antiepileptic drugs (AEDs): is it an issue?
    Bialer M
    Epilepsia; 2007 Oct; 48(10):1825-32. PubMed ID: 17850324
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Use of generic anti-epilepsy drugs in France: survey of neurologists and review of the literature].
    Biraben A; De Toffol B; Semah F; Rouaud T
    Rev Neurol (Paris); 2007 Apr; 163(4):455-61. PubMed ID: 17452947
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Generic antiepileptic drugs.
    Shaw SJ; Krauss GL
    Curr Treat Options Neurol; 2008 Jul; 10(4):260-8. PubMed ID: 18579013
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Requirements for generic antiepileptic medicines: a clinical perspective.
    Trinka E; Krämer G; Graf M
    J Neurol; 2011 Dec; 258(12):2128-32. PubMed ID: 21667222
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Generic products of antiepileptic drugs: a perspective on bioequivalence and interchangeability.
    Bialer M; Midha KK
    Epilepsia; 2010 Jun; 51(6):941-50. PubMed ID: 20384761
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Are there potential problems with generic substitution of antiepileptic drugs? A review of issues.
    Crawford P; Feely M; Guberman A; Kramer G
    Seizure; 2006 Apr; 15(3):165-76. PubMed ID: 16504545
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Generic substitution in the treatment of epilepsy: case evidence of breakthrough seizures.
    Berg MJ; Gross RA; Tomaszewski KJ; Zingaro WM; Haskins LS
    Neurology; 2008 Aug; 71(7):525-30. PubMed ID: 18695164
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The use of generic medication in epilepsy: a review of potential issues and challenges.
    Van Paesschen W; Hauman H; Lagae L
    Eur J Paediatr Neurol; 2009 Mar; 13(2):87-92. PubMed ID: 18790656
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Brand-to-generic levetiracetam switch in patients with epilepsy in a routine clinical setting.
    Markoula S; Chatzistefanidis D; Gatzonis S; Siatouni A; Siarava E; Verentzioti A; Kyritsis AP; Patsalos PN
    Seizure; 2017 May; 48():1-6. PubMed ID: 28363098
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Generic lamotrigine versus brand-name Lamictal bioequivalence in patients with epilepsy: A field test of the FDA bioequivalence standard.
    Ting TY; Jiang W; Lionberger R; Wong J; Jones JW; Kane MA; Krumholz A; Temple R; Polli JE
    Epilepsia; 2015 Sep; 56(9):1415-24. PubMed ID: 26201987
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Intrapatient variation in antiepileptic drug plasma concentration after generic substitution vs stable brand-name drug regimens.
    Contin M; Alberghini L; Candela C; Benini G; Riva R
    Epilepsy Res; 2016 May; 122():79-83. PubMed ID: 26987080
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Compulsory generic switching of antiepileptic drugs: high switchback rates to branded compounds compared with other drug classes.
    Andermann F; Duh MS; Gosselin A; Paradis PE
    Epilepsia; 2007 Mar; 48(3):464-9. PubMed ID: 17346246
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Therapeutic equivalency of generic antiepileptic drugs: results of a survey.
    Wilner AN
    Epilepsy Behav; 2004 Dec; 5(6):995-8. PubMed ID: 15582850
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Generic substitution in the treatment of epilepsy: patient and physician perceptions.
    Berg MJ; Gross RA; Haskins LS; Zingaro WM; Tomaszewski KJ
    Epilepsy Behav; 2008 Nov; 13(4):693-9. PubMed ID: 18589000
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.